Efficacy of infliximab for refractory pouchitis with complexed anal fistula

Efficacy of infliximab for refractory pouchitis with complexed anal fistula - Efficacy of infliximab for pouchitis with anal fistula

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014275

Enrollment

Registered

2014-06-24

Start date

2014-06-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

infliximab

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: pouchitis with anal fistula

Exclusion criteria

Exclusion criteria: Diagnosed with Crohn's disease or its suspiciousness

Design outcomes

Primary

Measure	Time frame
Assesment of healing rate of fistula and avoiding rate of re-ileostomy due to pouch failure.	—

Countries

Japan

Contacts

Public ContactMotoi Uchino

Hyogo College of Medicine Department of Inflammatory Bowel Disease

uchino2s@hyo-med.ac.jp0798-45-6371

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026